NCT03929887 KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
| NCT ID | NCT03929887 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Glomerular Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2019-05-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2019-05-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Glomerulonephritis (GN) generates an enormous individual and social economic burden. However, the therapeutic options are largely based on clinical and pathological parameters and the individual response to therapy or prognosis is uncertain. Recently, along with advances in molecular analysis and computational bioinformatics, genomic data from human renal biopsies could provide a strong foundation for the future of precision medicine in nephrology. In response to a request for applications by the Ministry of Health and Welfare of Korea for the creation of Clinical Research Registry, multi-center N network has been established for prospective cohort with kidney biopsy samples (KORNERSTONE). Through this Network the investigators hope to understand the fundamental biology of glomerulonephritis and aim to bank long-term observational data and corresponding biological data including genomic data from kidney tissues, and kidney pathologic data which is digitalized This database is archived to a web-based platform to access easily and further enrich for researchers.
Eligibility Criteria
1. Inclusion criteria * Patient suspected of glomerular disease who received kidney biopsy in participating university medical centers * Children (age\<18 years) also included 2. Exclusion criteria - Patients who previously received a kidney transplant
Contact & Investigator
Dong Ki Kim, MD, PhD
STUDY DIRECTOR
Seoul National University Hospital
Frequently Asked Questions
Who can join the NCT03929887 clinical trial?
This trial is open to participants of all sexes, studying Glomerular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03929887 currently recruiting?
Yes, NCT03929887 is actively recruiting participants. Contact the research team at imyongkim@gmail.com for enrollment information.
Where is the NCT03929887 trial being conducted?
This trial is being conducted at Chuncheon, South Korea, Daegu, South Korea, Seoul, South Korea, Seoul, South Korea and 2 additional locations.
Who is sponsoring the NCT03929887 clinical trial?
NCT03929887 is sponsored by Seoul National University Hospital. The principal investigator is Dong Ki Kim, MD, PhD at Seoul National University Hospital. The trial plans to enroll 3,000 participants.